Virios Therapeutics (VIRI) Tops Q3 EPS by 20c; Reports Cash Position of $19.2M

Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.49), $0.20 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Tutor Perini prices $400M in senior notes to refinance debt
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance